Skip to Content

ibr 140 mg (Imbruvica 140 mg)

Generic Name: ibrutinib

Pill with imprint ibr 140 mg is White, Capsule-shape and has been identified as Imbruvica 140 mg. It is supplied by Pharmacyclics Inc.

Imbruvica is used in the treatment of chronic lymphocytic leukemia; waldenström macroglobulinemia; non-hodgkin's lymphoma; mantle cell lymphoma; lymphoma and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 140 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ibr 140 mg

Imbruvica 140 mg ibr 140 mg
Imbruvica 140 mg ibr 140 mg
Imbruvica 140 mg ibr 140 mg

Imbruvica

Generic Name
ibrutinib
Imprint
ibr 140 mg
Strength
140 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
BTK inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pharmacyclics Inc
National Drug Code (NDC)
57962-0140

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.